{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T06:02:52Z","timestamp":1743919372528},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2253,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1111\/j.1365-2230.2008.03026.x","type":"journal-article","created":{"date-parts":[[2008,12,15]],"date-time":"2008-12-15T11:04:56Z","timestamp":1229339096000},"page":"582-586","source":"Crossref","is-referenced-by-count":12,"title":["Serum levels of transforming growth factor-\u03b21 in patients with mild psoriasis vulgaris and effect of treatment with biological drugs"],"prefix":"10.1093","volume":"34","author":[{"given":"P. G.","family":"Kallimanis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Xenos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"Markantonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Stavropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Margaroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Katsambas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Avgerinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","article-title":"Psoriasis","volume":"361","author":"Lebwohl","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000092283","article-title":"Epidemiology of psoriasis","volume":"212","author":"Schafer","year":"2006","journal-title":"Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB3","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaad.2005.04.035","article-title":"Psoriasis-recent advances in understanding its pathgenesis and treatment","volume":"53","author":"Krueger","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archderm.1991.01680050115015","article-title":"The cytokine network in psoriasis","volume":"127","author":"Nickoloff","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-4362.1999.00622.x","article-title":"Cytokines in psoriasis","volume":"38","author":"Bonifati","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/09629350310001619753","article-title":"Simultaneus measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity","volume":"12","author":"Jacob","year":"2003","journal-title":"Mediators Inflamm"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-\u03b1, IFN-\u03b3, IL-6,IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"5","author":"Arican","year":"2005","journal-title":"Mediators Inflamm"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/cyto.2002.1953","article-title":"Association between psoriasis severity and TGF-\u03b21 and TGF-\u03b22 in plasma and scales from psoriatic lesions","volume":"19","author":"Flisiak","year":"2002","journal-title":"Cytokine"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB9","first-page":"486","article-title":"The levels of transforming growth factor-\u03b21 are increased in the serum of patients and correlate with disease severity","volume":"6","author":"Bonifati","year":"1996","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/13547500310001599061","article-title":"Plasma TGF-\u03b21 as a biomarker of psoriasis activity and treatment efficacy","volume":"8","author":"Flisiak","year":"2003","journal-title":"Biomarkers"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB11","first-page":"363","article-title":"Transforming growth factor-beta: general review","volume":"7","author":"Lawrence","year":"1996","journal-title":"Eur Cytokine Netw"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.immunol.16.1.137","article-title":"Regulation of immune responses by TGF-b","volume":"16","author":"Letterio","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7326\/0003-4819-117-5-408","article-title":"Autocrine secretion-10\u2003years later","volume":"117","author":"Sporn","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB14","first-page":"2068","article-title":"Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium","volume":"46","author":"Shipley","year":"1986","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0167-5699(89)90136-9","article-title":"Inflammatory and immunomodulatory roles of TGF-\u03b2","volume":"10","author":"Wahl","year":"1989","journal-title":"Immunol Today"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis-oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB17","first-page":"2","article-title":"Serum concentrations of TGF-\u03b21 in patients with psoriasis vulgaris","volume":"12","author":"Nockowski","year":"2004","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI115821","article-title":"Transforming growth factor-beta in disease: the dark side of tissue repair","volume":"90","author":"Border","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB19","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/S0190-9622(03)01141-1","article-title":"Efalizumab: an overview","volume":"49","author":"Leonardi","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB20","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/mjd.2003.554","article-title":"Etanarcept: an overview","volume":"49","author":"Goffe","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.0906-6705.2004.00205.x","article-title":"Biology of tumor necrosis factor-\u03b1, implications for psoriasis","volume":"13","author":"Schottelius","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/1523-1747.ep12340553","article-title":"Transforming growth factor-\u03b21 receptor binding and function are decreased in psoriatic dermal endothelium","volume":"106","author":"Cai","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1365-2133.1998.02026.x","article-title":"Down-regulation of transforming growth factor-\u03b21 receptors I and II is seen in lesional but not in non-lesional psoriatic epidermis","volume":"138","author":"Leivo","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03026.x-BIB24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00918135","article-title":"Transforming growth factor-\u03b21 in inflammation: a cause and a cure","volume":"12","author":"Wahl","year":"1992","journal-title":"J Clin Immunol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2008.03026.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2008.03026.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:27:20Z","timestamp":1676384840000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/34\/5\/582\/6624992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2008.03026.x","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}